Presented by The Coalition to Strengthen America’s Healthcare — The Trump administration on Tuesday said it plans to limit ...

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

The Food and Drug Administration announced sweeping changes to its COVID-19 vaccine policy Tuesday, signaling a major ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

No, this is not true. Vaccines undergo rigorous safety testing and are continuously monitored for adverse events.

The requirement for placebo-controlled trials isn’t expected to affect the rollout this fall for older adults and other groups at high risk for severe illness.

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

It’s only the second time the World Health Assembly has adopted a health treaty, but key details of this Pandemic Agreement ...

The World Health Organization chief on Monday appealed to member countries to support its “extremely modest” request for a $2 ...

The vaccine, Nuvaxovid, is the third coronavirus shot to gain full approval, joining vaccines from Pfizer and Moderna. It has ...

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...

The FDA's full approval of Nuvaxovid triggered a $175 million milestone payment to Novavax from Sanofi, related to their ...